ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
CytoMed Therapeutics Ltd

CytoMed Therapeutics Ltd (GDTC)

2.64
0.05
(1.93%)
終了 2月2日 6:00AM
2.64
0.00
(0.00%)
取引時間後: 7:02AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
2.64
買値
2.31
売値
2.65
出来高
10,138
2.52 日の範囲 2.64
1.20 52 週間の範囲 3.98
時価総額
前日終値
2.59
始値
2.52
時刻
5
@
2.4
最終取引時間
財務取引量
US$ 26,132
VWAP
2.5776
平均取引量 (3 か月)
230,816
発行済株式数
11,540,000
配当利回り
-
PER
-7.37
1 株当たり利益 (EPS)
-0.36
歳入
518k
純利益
-4.13M

CytoMed Therapeutics Ltd について

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing C... CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Singapore, Sgp
設立
-
CytoMed Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker GDTC. The last closing price for CytoMed Therapeutics was US$2.59. Over the last year, CytoMed Therapeutics shares have traded in a share price range of US$ 1.20 to US$ 3.98.

CytoMed Therapeutics currently has 11,540,000 shares in issue. The market capitalisation of CytoMed Therapeutics is US$29.89 million. CytoMed Therapeutics has a price to earnings ratio (PE ratio) of -7.37.

GDTC 最新ニュース

CytoMed Therapeutics signs Business & Research Collaboration Agreement with India’s SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf Gamma Delta T Cells for treatment of solid cancers in a proposed Phase 2 clinical trial

SINGAPORE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on...

Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies

SINGAPORE, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Further to an announcement on October 7, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based...

CytoMed Therapeutics’ first-in-human Phase I ANGELICA clinical trial using its patented donor allogeneic chimeric antigen receptor T cell (CAR-T cell) against blood and solid tumors received co-funding support from the NMRC Clinical Trial Grant

SINGAPORE, Oct. 07, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.176.882591093122.472.712.32166672.54749478CS
4-0.86-24.57142857143.53.982.126842023.35690122CS
120.114.347826086962.533.981.83022308163.32748748CS
260.8547.48603351961.793.981.21062913.2601263CS
52-0.86-24.57142857143.53.981.2754772.98688271CS
156-1.36-3449.251.21197664.28377505CS
260-1.36-3449.251.21197664.28377505CS

GDTC - Frequently Asked Questions (FAQ)

What is the current CytoMed Therapeutics share price?
The current share price of CytoMed Therapeutics is US$ 2.64
How many CytoMed Therapeutics shares are in issue?
CytoMed Therapeutics has 11,540,000 shares in issue
What is the market cap of CytoMed Therapeutics?
The market capitalisation of CytoMed Therapeutics is USD 29.89M
What is the 1 year trading range for CytoMed Therapeutics share price?
CytoMed Therapeutics has traded in the range of US$ 1.20 to US$ 3.98 during the past year
What is the PE ratio of CytoMed Therapeutics?
The price to earnings ratio of CytoMed Therapeutics is -7.37
What is the cash to sales ratio of CytoMed Therapeutics?
The cash to sales ratio of CytoMed Therapeutics is 58.8
What is the reporting currency for CytoMed Therapeutics?
CytoMed Therapeutics reports financial results in SGD
What is the latest annual turnover for CytoMed Therapeutics?
The latest annual turnover of CytoMed Therapeutics is SGD 518k
What is the latest annual profit for CytoMed Therapeutics?
The latest annual profit of CytoMed Therapeutics is SGD -4.13M
What is the registered address of CytoMed Therapeutics?
The registered address for CytoMed Therapeutics is #08-22 ONE COMMONWEALTH, 1 COMMONWEALTH LANE, SINGAPORE, 149544
What is the CytoMed Therapeutics website address?
The website address for CytoMed Therapeutics is www.cytomed.sg.
Which industry sector does CytoMed Therapeutics operate in?
CytoMed Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
729.72M
REBNReborn Coffee Inc
US$ 3.31
(63.05%)
55.54M
FCUVFocus Universal Inc
US$ 5.87
(56.62%)
1.73M
SOPASociety Pass Inc
US$ 1.54
(56.50%)
13.82M
CYCNCyclerion Therapeutics Inc
US$ 3.92
(54.33%)
82.39M
ENVBEnveric Biosciences Inc
US$ 2.0899
(-46.41%)
1.57M
NIVFNewGenIvf Group Ltd
US$ 0.1489
(-42.51%)
14.8M
GLSTGlobal Star Acquisition Inc
US$ 8.83
(-39.10%)
23.89k
PRPHProPhase Labs Inc
US$ 0.2633
(-38.02%)
872.46k
SPGCSacks Parente Golf Inc
US$ 0.5601
(-37.86%)
7.27M
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
731.1M
NVDANVIDIA Corporation
US$ 120.07
(-3.67%)
388.5M
RIMEAlgorhythm Holdings Inc
US$ 0.02565
(5.12%)
341.8M
CLEUChina Liberal Education Holdings Ltd
US$ 0.1938
(30.77%)
237.15M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0355
(-11.25%)
236.44M

最近閲覧した銘柄

Delayed Upgrade Clock